Exelon Corporation Common Stock vs GSK plc — how do they compare? Exelon Corporation Common Stock trades at $41.73 (market cap $42.99B), while GSK plc trades at $46.54 (market cap $91.88B). The key difference: GSK plc is far larger — about 2.1× Exelon Corporation Common Stock's market cap, and Exelon Corporation Common Stock pays the higher dividend (4.03%). Which is the better fit depends on your goals.
| EXC | GSK | |
|---|---|---|
Market Cap | $42.99B | $91.88B |
Volume | 7,570,408 | 7,730,529 |
Sector | Utilities | Health |
52-Week High | $50.29 | $61.18 |
52-Week Low | $40.20 | $43.24 |
Enterprise Value | $93.85B | $111.88B |
Dividend Yield | 4.03% | 3.9% |
Typical Hold Time | — | 93 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GSK trades at $46.50, down 1.11% with bearish technical signals, though RSI levels suggest potential oversold conditions. Fundamentally, the company shows strong profitability with 72.73% gross margins and consistent earnings beats, while maintaining a reasonable P/E of 14.89. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite facing an HIV patent cliff.
GSK presents a mixed investment case with strong fundamentals and pipeline growth offset by technical weakness and patent expiration risks. The company's £40B sales target and cost-saving initiatives provide upside potential, while analyst consensus leans cautious with 55% hold ratings. Key risks include execution of pipeline development and competitive pressures in core markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →